Alchemia Ltd - Product Pipeline Review

Global Markets Direct’s, ‘Alchemia Ltd - Product Pipeline Review - 2016’, provides an overview of the Alchemia Ltd’s pharmaceutical research and development focus.

The report provides comprehensive information on the therapeutics under development by Alchemia Ltd, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and the dormant and discontinued projects.

Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct’s proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data.

Scope

The report provides a snapshot of the pipeline therapeutic landscape of Alchemia Ltd

The report provides overview of Alchemia Ltd including its business description, key facts, and locations and subsidiaries

The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities

The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages

The report assesses Alchemia Ltd’s pipeline therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type

The report features Alchemia Ltd’s out-licensed and partnered product portfolio and summarizes its dormant and discontinued projects

Reasons to buy

Evaluate Alchemia Ltd’s strategic position with total access to detailed information on its product pipeline

Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies

Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

Identify and understand important and diverse types of therapeutics under development for Alchemia Ltd

Identify potential new clients or partners in the target demographic

Plan mergers and acquisitions effectively by identifying key players and it’s most promising pipeline therapeutics

Devise corrective measures for pipeline projects by understanding Alchemia Ltd’s pipeline depth and focus of pipeline therapeutics

Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope

Table of Contents

Table of Contents

Table of Contents 2

List of Tables 4

List of Figures 4

Alchemia Ltd Snapshot 5

Alchemia Ltd Overview 5

Key Facts ...

Table of Contents

Table of Contents 2

List of Tables 4

List of Figures 4

Alchemia Ltd Snapshot 5

Alchemia Ltd Overview 5

Key Facts 5

Alchemia Ltd - Research and Development Overview 6

Key Therapeutic Areas 6

Alchemia Ltd - Pipeline Review 9

Pipeline Products by Stage of Development 9

Pipeline Products - Monotherapy 10

Alchemia Ltd - Pipeline Products Glance 11

Alchemia Ltd - Clinical Stage Pipeline Products 11

Phase II Products/Combination Treatment Modalities 11

Alchemia Ltd - Early Stage Pipeline Products 12

Preclinical Products/Combination Treatment Modalities 12

Discovery Products/Combination Treatment Modalities 13

Alchemia Ltd - Drug Profiles 14

HA-5FU - Drug Profile 14

Product Description 14

Mechanism Of Action 14

R&D Progress 14

HA-Doxorubicin - Drug Profile 15

Product Description 15

Mechanism Of Action 15

R&D Progress 15

irinotecan hydrochloride - Drug Profile 16

Product Description 16

Mechanism Of Action 16

R&D Progress 16

Monoclonal Antibody 2 to Target CD44 for Oncology - Drug Profile 20

Product Description 20

Mechanism Of Action 20

R&D Progress 20

Small Molecules for Respiratory, Oncology, Cardiovascular, Metabolic Disorders, Infectious Disease and Neurology - Drug Profile 21

Product Description 21

Mechanism Of Action 21

R&D Progress 21

Small Molecules to Inhibit Glycosyltransferase for Bacterial Infections - Drug Profile 22

Product Description 22

Mechanism Of Action 22

R&D Progress 22

Small Molecules to Inhibit Glycosyltransferase for Gram-Positive Bacterial Infection - Drug Profile 23

Product Description 23

Mechanism Of Action 23

R&D Progress 23

Alchemia Ltd - Pipeline Analysis 24

Alchemia Ltd - Pipeline Products by Target 24

Alchemia Ltd - Pipeline Products by Route of Administration 25

Alchemia Ltd - Pipeline Products by Molecule Type 26

Alchemia Ltd - Pipeline Products by Mechanism of Action 27

Alchemia Ltd - Dormant Projects 28

Alchemia Ltd - Discontinued Pipeline Products 29

Discontinued Pipeline Product Profiles 29

ACL-16907 29

VAST Based Drug For Obesity 29

Alchemia Ltd - Locations And Subsidiaries 30

Head Office 30

Other Locations & Subsidiaries 30

Appendix 31

Methodology 31

Coverage 31

Secondary Research 31

Primary Research 31

Expert Panel Validation 31

Contact Us 31

Disclaimer 32

List of Tables

List of Tables

Alchemia Ltd, Key Facts 5

Alchemia Ltd - Pipeline by Indication, 2016 8

Alchemia Ltd - Pipeline by Stage of Development, 2016 9

Alchemia ...

List of Tables

Alchemia Ltd, Key Facts 5

Alchemia Ltd - Pipeline by Indication, 2016 8

Alchemia Ltd - Pipeline by Stage of Development, 2016 9

Alchemia Ltd - Monotherapy Products in Pipeline, 2016 10

Alchemia Ltd - Phase II, 2016 11

Alchemia Ltd - Preclinical, 2016 12

Alchemia Ltd - Discovery, 2016 13

Alchemia Ltd - Pipeline by Target, 2016 24

Alchemia Ltd - Pipeline by Route of Administration, 2016 25

Alchemia Ltd - Pipeline by Molecule Type, 2016 26

Alchemia Ltd - Pipeline Products by Mechanism of Action, 2016 27

Alchemia Ltd - Dormant Developmental Projects,2016 28

Alchemia Ltd - Discontinued Pipeline Products, 2016 29

Alchemia Ltd, Subsidiaries 30

List of Figures

List of Figures

Alchemia Ltd - Pipeline by Top 10 Indication, 2016 7

Alchemia Ltd - Pipeline by Stage of Development, 2016 9

Alchemia Ltd - Monotherapy Products ...

List of Figures

Alchemia Ltd - Pipeline by Top 10 Indication, 2016 7

Alchemia Ltd - Pipeline by Stage of Development, 2016 9

Alchemia Ltd - Monotherapy Products in Pipeline, 2016 10

Alchemia Ltd - Pipeline by Target, 2016 24

Alchemia Ltd - Pipeline by Molecule Type, 2016 26

Alchemia Ltd - Pipeline Products by Mechanism of Action, 2016 27

    Pricing

Discounts available for multiple report purchases.

reportstore@globalmarketsdirect.com
+44 (0) 161 359 5414

Saved reports